e-learning
resources
London 2016
Wednesday, 07.09.2016
Pleural diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Contribution of PIPE Score on prognostic evaluation of idiopathic pleural effusions (IPE)
Maria Alejandra Galarza Jimenez (Madrid, Spain), Maria Alejandra Galarza Jimenez, Esteban Pérez-Rodríguez, Paola Lucía Arrieta-Narváez, Rosa Mariela Mirambeaux-Villalona, Patricia Castro-Acosta, Beatriz Martín-García, Ana Soledad Jaureguizar-Oriol
Source:
International Congress 2016 – Pleural diseases
Session:
Pleural diseases
Session type:
Poster Discussion
Number:
5042
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Maria Alejandra Galarza Jimenez (Madrid, Spain), Maria Alejandra Galarza Jimenez, Esteban Pérez-Rodríguez, Paola Lucía Arrieta-Narváez, Rosa Mariela Mirambeaux-Villalona, Patricia Castro-Acosta, Beatriz Martín-García, Ana Soledad Jaureguizar-Oriol. Contribution of PIPE Score on prognostic evaluation of idiopathic pleural effusions (IPE). Eur Respir J 2016; 48: Suppl. 60, 5042
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Idiopathic pleural effusions (IPE) and predictive prognosis
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015
A simple score based on ultrasound criteria to distinguish between exudative vs. transudative pleural effusions
Source: International Congress 2014 – Different modalities and techniques for lung imaging
Year: 2014
Score evaluation to management of parapneumonic effusion (PPE) in children
Source: Eur Respir J 2002; 20: Suppl. 38, 590s
Year: 2002
Modified Glasgow Prognostic Score – a predictor of survival in malignant pleural effusion
Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease
Year: 2021
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020
Specialist clinic for exudative pleural effusions (EPE) improves outcome
Source: Annual Congress 2008 - Pleural diseases and interventions
Year: 2008
Prognostic features of residual pleural thickening after parapneumonic pleural effusion
Source: Eur Respir J 2002; 20: Suppl. 38, 605s
Year: 2002
Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Evaluation of patients with pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 247s
Year: 2004
The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion
Source: Eur Respir J, 55 (5) 1900980; 10.1183/13993003.00980-2019
Year: 2020
Tool methods in the diagnosis of pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 628s
Year: 2004
Diagnostic assessment in tuberculous pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 413s
Year: 2005
Diagnostic and prognostic utility of eosinophilic pleural effusions(PE)
Source: Eur Respir J 2002; 20: Suppl. 38, 440s
Year: 2002
Algorithm for diagnostics of recurrent pleural effusions suspected to malignancy
Source: Eur Respir J 2006; 28: Suppl. 50, 88s
Year: 2006
Diagnostic utility of eosinophilic pleural effusion: A ten years series
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010
Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Diagnostic accuracy of drop-peroxide test to differentiate transudative and exudative pleural effusion
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1
Year: 2020
Malignant pleural effusions: from the diagnosis to the management
Source: International Congress 2015 – ME2 Malignant pleural effusions: from diagnosis to management
Year: 2015
Malignant pleural effusions: diagnosis and management
Source: International Congress 2017 – PG5 Pleural disease management
Year: 2017
Recurrent pleural effusion : algorithm for diagnosis and treatment
Source: Annual Congress 2004 - PG20 - State-of-the art in management of pleural diseases
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept